# EDGAR Filing Document

**Accession Number:** 0001857475
**File Stem:** 0001857475-26-000014
**Filing Date:** 2026-2
**Character Count:** 88982
**Document Hash:** 85bfd4ab5ad87a89d08ca4d0c492d575
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001857475-26-000014.hdr.sgml**: 20260225

**ACCESSION NUMBER**: 0001857475-26-000014

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260225

**ITEM INFORMATION**: Results of Operations and Financial Condition

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260225

**DATE AS OF CHANGE**: 20260225

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Dole plc
- **CENTRAL INDEX KEY:** 0001857475
- **STANDARD INDUSTRIAL CLASSIFICATION:** AGRICULTURE PRODUCTION - CROPS [0100]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40695
- **FILM NUMBER:** 26674006

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 29 NORTH ANNE STREET
- **CITY:** DUBLIN
- **PROVINCE COUNTRY:** L2
- **BUSINESS PHONE:** 353 1 88 72745

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 29 NORTH ANNE STREET
- **CITY:** DUBLIN
- **PROVINCE COUNTRY:** L2

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Dole Ltd
- **DATE OF NAME CHANGE:** 20210416

?xml version='1.0' encoding='ASCII'? dole-20260225

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934**

**Date of Report (Date of Earliest Event Reported): February 25, 2026**

---

| |
|:---|
| **Dole plc** |
| **(Exact Name of Registrant as Specified in Charter)** |

---

---

| | | |
|:---|:---|:---|
| **Ireland** | **001-40695** | &nbsp;&nbsp;&nbsp;&nbsp;**98-1610692** |
| **(State or other jurisdiction &nbsp;&nbsp;&nbsp;&nbsp;**<br>**&nbsp;&nbsp;&nbsp;&nbsp; of incorporation)**  | **(Commission File Number)&nbsp;&nbsp;&nbsp;&nbsp;** | **(I.R.S. Employer Identification No.)**  |

---

**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;** 

 **29 North Anne Street, Dublin 7, D07 PH36, Ireland**

**101 South Tryon Street, Suite 600, Charlotte, NC**

**United States 28280**

(Address of principal executive offices)

Registrant's telephone number, including area code: **353-1-887-2600**

**Not applicable**

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol (s)** | **Name of each exchange on which registered** |
| Ordinary Shares, $0.01 Par Value Per Share | DOLE | New York Stock Exchange |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐

------

**Item 2.02. Results of Operations and Financial Condition.**

On February 25, 2026, Dole plc (the "Company") issued a press release disclosing its financial results for the three months and year ended December 31, 2025. A copy of the press release is attached to this Current Form on 8-K as Exhibit 99.1.

**Item 7.01. Regulation FD Disclosure.**

At 08:00 a.m. Eastern Time on February 25, 2026, the Company will host a conference call and simultaneous webcast to discuss its financial results for the three months and year ended December 31, 2025. An archived replay of the webcast and the investor presentation used during the webcast will be available shortly after the live event has concluded in the Investors section of the Company's website, www.doleplc.com/investors.

The information being furnished pursuant to Item 2.02, including Exhibit 99.1, and Item 7.01 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall expressly set forth by specific reference in such filing.

**Item 9.01. Financial Statements and Exhibits.**

---

| | |
|:---|:---|
| 99.1 | &nbsp;&nbsp;<u>[Dole plc Press Release issued February 25, 2026 – Dole plc Reports Fourth Quarter and Full Year 2025 Financial Results](doleplcreportsfourthquarte.htm)</u> |
| 104 | &nbsp;&nbsp;Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

------

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
| Date: | February 25, 2026 | **DOLE PLC** |
|  |  | (Registrant) |
|  |  | By: /s/ Jacinta Devine |
|  |  | Name: Jacinta Devine |
|  |  | Title: Chief Financial Officer |

---

## Exhibit 99.1

**Exhibit 99.1**

**Dole plc Reports Fourth Quarter and Full Year 2025 Financial Results** 

DUBLIN – February 25, 2026 - Dole plc (NYSE: DOLE) ("Dole" or the "Group" or the "Company") today released its financial results for the three months and year ended December 31, 2025.

**Fourth Quarter Highlights:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Positive fourth quarter operational performance for the Group

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenue of $2.4 billion, an increase of 9.2%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net Income of $6.0 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**•** Adjusted EBITDA<sup>1</sup> of $72.7 million, ahead of market expectations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted Net Income<sup>1</sup> of $13.8 million

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Announced Agreement to sell port assets in Ecuador for expected net proceeds of approximately $75 million

**Full Year Highlights:**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Robust full year performance driven by strong growth across the two Diversified segments, offsetting an anticipated decline in Fresh Fruit

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Revenue of $9.2 billion, an increase of 8.2%

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net Income of $82.0 million, and Diluted EPS of $0.53

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted EBITDA<sup>1</sup> of $395.4 million, ahead of our latest guidance and market expectations

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Adjusted Net Income<sup>1</sup> of $115.0 million and Adjusted Diluted EPS of $1.20

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Net Debt<sup>1</sup> of $606.5 million, a reduction of $30.7 million, and Net Leverage<sup>1</sup> of 1.5x

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Board authorization granted for share repurchases up to $100 million in the aggregate

**Financial Highlights**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Year Ended** | **Year Ended** |
| | **December 31, 2025** | **December 31, 2024** | **December 31, 2025** | **December 31, 2024** |
|  | *(U.S. Dollars in millions, except per share amounts) (Unaudited)* | *(U.S. Dollars in millions, except per share amounts) (Unaudited)* | *(U.S. Dollars in millions, except per share amounts) (Unaudited)* | *(U.S. Dollars in millions, except per share amounts) (Unaudited)* |
| Revenue | 2366  | 2167  | 9173  | 8475  |
| Income from Continuing Operations<sup>2</sup> | 6.8  | 29.6  | 127.9  | 172.3  |
| Net Income (Loss) | 6.0  | (31.6) | 82.0  | 143.4  |
| Net (Loss) Income attributable to Dole plc | (2.7) | (39.1) | 51.3  | 125.5  |
| Diluted EPS from Continuing Operations | (0.02) | 0.23  | 1.01  | 1.62  |
| Diluted EPS | (0.03) | (0.41) | 0.53  | 1.32  |
| Adjusted EBITDA<sup>1</sup> | 72.7  | 74.6  | 395.4  | 392.2  |
| Adjusted Net Income<sup>1</sup> | 13.8  | 15.3  | 115.0  | 120.9  |
| Adjusted Diluted EPS<sup>1</sup> | 0.14  | 0.16  | 1.20  | 1.27  |

---

Commenting on the results, Carl McCann, Executive Chairman, said:

*"We are very pleased to deliver a strong operating result for the year, with Adjusted EBITDA of $395 million, surpassing our most recent guidance.* 

*In 2025, the Group achieved several significant strategic milestones, including the sale of the Fresh Vegetables business, the initiation of a $100 million share repurchase program, and our transition to U.S. Domestic Issuer filings as we target further index inclusion.*

*The Group continues to demonstrate strong operational momentum. For the coming financial year, we are targeting Adjusted EBITDA of at least $400 million."*

------

**Group Results - Fourth Quarter**

Revenue increased 9.2%, or $198.7 million, primarily due to positive operational performance across all segments, as well as a favorable impact from foreign currency translation of $77.1 million, offset partially by a net negative impact from acquisitions and divestitures of $3.0 million. On a like-for-like basis<sup>3</sup>, revenue increased 5.7%, or $124.6 million.

Net income increased to $6.0 million from a loss of $31.6 million in the prior year. The prior year was impacted by a loss of $61.2 million in discontinued operations (Fresh Vegetables division). On a continuing operations basis, net income decreased from $29.6 million to $6.8 million primarily due to the impact of a non-cash discrete tax charge recorded in the current year, offset partially by higher equity method earnings.

Adjusted EBITDA decreased 2.6%, or $1.9 million, primarily driven by higher fruit costs in the Fresh Fruit segment. These decreases were partially offset by good performance in our Diversified Fresh Produce - Americas & ROW segment, as well as a favorable impact of foreign currency translation of $3.2 million. On a like-for-like basis, Adjusted EBITDA decreased 6.1%, or $4.5 million.

Adjusted Net Income decreased 9.8%, or $1.5 million, predominantly due to the decreases in Adjusted EBITDA noted above and higher depreciation expense, partially offset by lower interest expense. Adjusted Diluted EPS for the three months ended December 31, 2025 was $0.14 compared to $0.16 in the prior year.

**Group Results - Full Year**

Revenue increased 8.2%, or $697.6 million, primarily due to strong operational performances across all segments and a favorable impact from foreign currency translation of $169.4 million. These positive impacts were partially offset by a net negative impact from acquisitions and divestitures of $111.0 million. On a like-for-like basis, revenue increased 7.5%, or $639.2 million.

Net income decreased to $82.0 million from $143.4 million in the prior year. The prior year benefitted from a gain on the disposal of the Progressive Produce business. The current year was impacted by a higher loss in discontinued operations, non-cash fair value losses on financial instruments, a non-cash discrete tax charge and impairment charges on assets, primarily those excluded from the disposal of the Fresh Vegetables division. These decreases were partially offset by insurance proceeds recognized in the period, higher equity method earnings, lower interest expense and higher gains on asset sales.

Adjusted EBITDA increased 0.8%, or $3.2 million, primarily due to good performance in the Diversified Fresh Produce - Americas & ROW and Diversified Fresh Produce - EMEA segments as well as a favorable impact of foreign currency translation of $7.2 million, partially offset by a decrease in the Fresh Fruit segment driven by higher fruit costs, and a net negative impact from acquisitions and divestitures of $2.1 million. On a like-for-like basis, Adjusted EBITDA decreased 0.5%, or $1.9 million.

Adjusted Net Income decreased 4.8%, or $5.9 million, predominantly due to higher depreciation expense, offset partially by the increases in Adjusted EBITDA noted above and lower interest expense. Adjusted Diluted EPS for the year ended December 31, 2025 was $1.20 compared to $1.27 in the prior year.

------

**Selected Segmental Financial Information**

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** | **Three Months Ended** |
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2024** | **December 31, 2024** |
|  | *(U.S. Dollars in thousands) (unaudited)* | *(U.S. Dollars in thousands) (unaudited)* | *(U.S. Dollars in thousands) (unaudited)* | *(U.S. Dollars in thousands) (unaudited)* |
|  | **Revenue** | **Adjusted EBITDA**<sup>1</sup> | **Revenue** | **Adjusted EBITDA**<sup>1</sup> |
| Fresh Fruit | $874036  | $26602  | $819066  | $31890  |
| Diversified Fresh Produce - EMEA | 1025887  | 32597  | 910604  | 32487  |
| Diversified Fresh Produce - Americas & ROW | 486455  | 13468  | 463285  | 10234  |
| Intersegment | (20216) | —  | (25491) | —  |
| **Total** | $**2366162**  | $**72667**  | $**2167464**  | $**74611**  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Year Ended** | **Year Ended** | **Year Ended** | **Year Ended** |
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2024** | **December 31, 2024** |
|  | *(U.S. Dollars in thousands) (unaudited)* | *(U.S. Dollars in thousands) (unaudited)* | *(U.S. Dollars in thousands) (unaudited)* | *(U.S. Dollars in thousands) (unaudited)* |
|  | **Revenue** | **Adjusted EBITDA**<sup>1</sup> | **Revenue** | **Adjusted EBITDA**<sup>1</sup> |
| Fresh Fruit | $3615127  | $189842  | $3293527  | $214848  |
| Diversified Fresh Produce - EMEA | 4016573  | 149981  | 3608692  | 131504  |
| Diversified Fresh Produce - Americas & ROW | 1656207  | 55553  | 1686281  | 45851  |
| Intersegment | (115000) | —  | (113157) | —  |
| **Total** | $**9172907**  | $**395376**  | $**8475343**  | $**392203**  |

---

**Fourth Quarter Segmental Commentary**

***Fresh Fruit***

Revenue increased 6.7%, or $55.0 million, primarily due to higher worldwide volumes of bananas sold, as well as higher worldwide pricing of bananas, pineapples and plantains, partially offset by lower worldwide volumes of pineapples and plantains sold.

Adjusted EBITDA decreased 16.6%, or $5.3 million, primarily driven by higher fruit costs in bananas, due both to higher overall sourcing costs in the market and higher fruit costs following Tropical Storm Sara. In the quarter, we also experienced higher fruit sourcing costs and lower volumes in pineapples and higher sourcing costs in plantains. These decreases were partially offset by higher profits in commercial cargo.

***Diversified Fresh Produce – EMEA***

Revenue increased 12.7%, or $115.3 million, primarily driven by a favorable impact of foreign currency translation of $77.0 million, as a result of the strengthening of the Swedish krona, euro and British pound sterling against the U.S. Dollar, as well as strong underlying performance in Spain, France and South Africa. These increases were partially offset by a net negative impact from acquisitions and divestitures of $3.0 million. On a like-for-like basis, revenue increased 4.5%, or $41.3 million.

Adjusted EBITDA increased 0.3%, or $0.1 million, primarily due to increased earnings in Scandinavia, Ireland and Spain, as well as a favorable impact from foreign currency translation of $3.7 million. These increases were partially offset by decreased underlying earnings in the U.K. and the Netherlands. On a like-for-like basis, Adjusted EBITDA decreased 10.8%, or $3.5 million.

------

***Diversified Fresh Produce – Americas & ROW***

Revenue increased 5.0%, or $23.2 million, primarily due to revenue growth in most commodities sold in the North American market as well as revenue growth in the southern hemisphere export products, primarily driven by higher cherry volumes and higher blueberry pricing.

Adjusted EBITDA increased 31.6%, or $3.2 million, primarily due to improved profitability in our joint venture businesses, as well as by earnings growth in our southern hemisphere export business, driven particularly by higher cherry volumes.

**Full Year Segmental Commentary**

***Fresh Fruit***

Revenue increased 9.8%, or $321.6 million, primarily driven by higher worldwide volumes of bananas and pineapples sold, as well as higher worldwide pricing of bananas, pineapples and plantains, partially offset by lower worldwide volumes of plantains sold.

Adjusted EBITDA decreased 11.6%, or $25.0 million, primarily driven by higher fruit costs, due both to higher overall sourcing costs in the market and higher fruit costs following Tropical Storm Sara, as well as higher shipping costs due to the completion of scheduled dry dockings and a short term operational disruption to one of our vessels servicing the North American market. These challenges were partially offset by an improved performance in pineapples.

***Diversified Fresh Produce – EMEA***

Revenue increased 11.3%, or $407.9 million, primarily driven by strong performance in Spain, the U.K., the Netherlands and Scandinavia, as well as a favorable impact from foreign currency translation of $172.0 million, as a result of the strengthening of the Swedish krona, euro and the British pound sterling against the U.S. Dollar. These increases were partially offset by a net negative impact from acquisitions and divestitures of $31.7 million. On a like-for-like basis, revenue increased 7.4%, or $267.6 million.

Adjusted EBITDA increased 14.1%, or $18.5 million, primarily driven by increases in earnings in Spain, Scandinavia, the Netherlands and the Czech Republic, as well as a favorable impact from foreign currency translation of $8.3 million. On a like-for-like basis, Adjusted EBITDA increased 7.7%, or $10.1 million.

***Diversified Fresh Produce – Americas & ROW***

Revenue decreased 1.8%, or $30.1 million, primarily due to the disposal of the Progressive Produce business in mid-March 2024. On a like-for-like basis, revenue increased 3.1%, or $52.6 million, primarily due to increases in the North American market due to higher revenues for the majority of commodities sold, partially offset by lower export pricing in some key southern hemisphere export products.

Adjusted EBITDA increased 21.2%, or $9.7 million, primarily due to strong performance in the North American market in kiwi and citrus, as well as by an increase for southern hemisphere export products and increased profitability in our joint venture businesses. On a like-for-like basis, Adjusted EBITDA increased 28.1% or $12.9 million.

**Capital Expenditures**

Capital expenditures from continuing operations for the year ended December 31, 2025 were $121.5 million, including the buyout of two vessel finance leases of $36.1 million that were already reflected within Net Debt as of December 31, 2024. Other expenditures included investments in the rehabilitation of the impacted farms in Honduras following Tropical Storm Sara (investments that are materially supported by insurance proceeds of $18.0 million), investments in warehouse and logistics assets, particularly in Northern Europe, vessel dry dockings, other farming investments and ongoing investments in IT assets. Additions through finance leases from continuing operations were $15.6 million for the year ended December 31, 2025.

------

**Free Cash Flow from Continuing Operations, Net Debt and Net Leverage**

Free cash flow from continuing operations was $1.7 million for the year ended December 31, 2025, compared to $180.3 million for the year ended December 31, 2024. There were higher outflows from receivables due to the increase in revenue, higher advances to growers and lower securitization of trade receivables along with lower inflows from accounts payables and accrued liabilities. There was also an increase in tax payments due to cash tax paid on sale of the Fresh Vegetables division, higher repatriation tax and timing of payments. In addition there were higher cash capital expenditures due to buyout of two vessel finance leases and rehabilitation of farms in Honduras as noted above.

At the end of the year, Net Debt was $606.5 million, a reduction from $637.1 million as of December 31, 2024. Net Leverage decreased to 1.5x as of December 31, 2025 from 1.6x as of December 31, 2024.

**Dividend**

On February 24, 2026, the Board of Directors of Dole plc declared a cash dividend for the fourth quarter of 2025 of $0.085 per share, payable on April 8, 2026 to shareholders of record on March 18, 2026. A cash dividend of $0.085 per share was paid on January 3, 2026 for the third quarter of 2025.

**Share Repurchase Program**

Post year-end, we repurchased 300,000 shares at an average price of $15.15 per share, totaling $4.5 million. $95.5 million remains available under the share repurchase program.

**Outlook for Fiscal Year 2026 (forward-looking statement)**

We are very pleased with the operating result for 2025, delivering Adjusted EBITDA of $395 million, which came in ahead of our latest guidance. The result is a testament to the experience and skill of our people in a year a year of macroeconomic uncertainty and other industry specific factors.

We made important strategic steps forward during 2025, in particular completing the sale of the Fresh Vegetables business. Today, our business is in a good position, with strong operational momentum across the group.

With this platform, we are targeting growth for fiscal year 2026, and at this early stage of the year we are targeting Adjusted EBITDA of at least $400 million.

For fiscal year 2026, we are forecasting routine capex of approximately $100 million, which is broadly in line with our annual depreciation charge. In addition, we continue to explore a range of development opportunities which, if executed, will strengthen our business and continue to drive further growth in the years to come.

Under the assumption that base rates will remain broadly stable in 2026, we expect full year interest expense to be approximately $60 million for 2026.

**Footnote Index**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.Refer to the Appendix of this release for an explanation and reconciliation of non-GAAP financial measures used in this release to comparable GAAP financial measures.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Fresh Vegetables results are reported separately as discontinued operations, net of income taxes, in our consolidated statements of operations, its assets and liabilities are separately presented in our consolidated balance sheets, and its cash flows are presented separately in our consolidated statements of cash flows for all periods presented. Unless otherwise noted, our discussion of our results included herein, outlook and all supplementary tables, including non-GAAP financial measures, are presented on a continuing operations basis.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.Like-for-like basis refers to the measure excluding the impact of foreign currency translation movements and acquisition and divestitures. Refer to the Appendix and "Supplementary Reconciliation of Prior Year Segment Results to Current Year Segment Results" for further detail on these impacts and the calculation of like-for-like basis variances.

------

**About Dole plc**

A global leader in fresh produce, Dole plc produces, markets, and distributes an extensive variety of fresh fruits and vegetables sourced locally and from around the world. Dedicated and passionate in exceeding our customers' requirements in over 85 countries, our goal is to make the world a healthier and a more sustainable place.

**Webcast and Conference Call Information**

Dole plc will host a conference call and simultaneous webcast at 08:00 a.m. Eastern Time today to discuss the fourth quarter and full year 2025 financial results. The live webcast and a replay after the event can be accessed at www.doleplc.com/investor-relations or directly at https://events.q4inc.com/attendee/266987087.

**Forward-looking information**

Certain statements made in this press release that are not historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are based on management's beliefs, assumptions, and expectations of our future economic performance, considering the information currently available to management. These statements are not statements of historical fact. The words "believe," "may," "could," "will," "should," "would," "anticipate," "estimate," "expect," "intend," "objective," "seek," "strive," "target" or similar words, or the negative of these words, identify forward-looking statements. The inclusion of this forward-looking information should not be regarded as a representation by us or any other person that the future plans, estimates, or expectations contemplated by us will be achieved. Such forward-looking statements are subject to various risks and uncertainties and assumptions relating to our operations, financial results, financial condition, business prospects, growth strategy and liquidity. Accordingly, there are, or will be, important factors that could cause our actual results to differ materially from those indicated in these statements. If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. We caution that you should not place undue reliance on any of our forward-looking statements. Any forward-looking statement speaks only as of the date on which such statement is made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made except as required by the federal securities laws.

**Investor Contact:**

James O'Regan, Head of Investor Relations, Dole plc

*<u>james.oregan@doleplc.com</u>* 

+353 1 887 2794

**Media Contact:**

Brian Bell, Ogilvy

*<u>brian.bell@ogilvy.com</u>* 

+353 87 2436 130

**Category: Financial**

------

**Appendix**

**Consolidated Statements of Operations - Unaudited** 

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Year Ended** | **Year Ended** |
| | **December 31, 2025** | **December 31, 2024** | **December 31, 2025** | **December 31, 2024** |
|  | *(U.S. Dollars and shares in thousands, except per share amounts)* | *(U.S. Dollars and shares in thousands, except per share amounts)* | *(U.S. Dollars and shares in thousands, except per share amounts)* | *(U.S. Dollars and shares in thousands, except per share amounts)* |
| Revenue, net | $2366161  | $2167464  | $9172907  | $8475343  |
| Cost of sales | (2207527) | (2009045) | (8458599) | (7757622) |
| &nbsp;&nbsp;&nbsp;&nbsp;Gross profit | 158634  | 158419  | 714308  | 717721  |
| Selling, marketing, general and administrative expenses | (129135) | (122675) | (495476) | (474058) |
| Gain on disposal of businesses | 54  | 472  | 606  | 76417  |
| Gain on asset sales | 1079  | 747  | 15045  | 2648  |
| Impairment of goodwill | —  | —  | —  | (36684) |
| Impairment and asset write-downs of property, plant and equipment and lease assets | (2942) | (2154) | (11518) | (5480) |
| &nbsp;&nbsp;&nbsp;&nbsp;Operating income | 27690  | 34809  | 222965  | 280564  |
| Other income (expense), net | 4876  | 11137  | (1574) | 20595  |
| Interest income | 3900  | 2410  | 13373  | 10745  |
| Interest expense | (15202) | (18055) | (66541) | (72264) |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations before income taxes and equity earnings | 21264  | 30301  | 168223  | 239640  |
| Income tax expense | (21821) | (264) | (71003) | (75649) |
| Equity method earnings (loss) | 7362  | (403) | 30714  | 8308  |
| &nbsp;&nbsp;&nbsp;&nbsp;Income from continuing operations  | 6805  | 29634  | 127934  | 172299  |
| &nbsp;&nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | (803) | (61231) | (45959) | (28880) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net income (loss) | 6002  | (31597) | 81975  | 143419  |
| &nbsp;&nbsp;&nbsp;&nbsp;Less: Net income attributable to noncontrolling interests | (8666) | (7552) | (30656) | (17906) |
| &nbsp;&nbsp;&nbsp;&nbsp;Net (loss) income attributable to Dole plc | $(2664) | $(39149) | $51319  | $125513  |
| Income (loss) per share - basic: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | $(0.02) | $0.23  | $1.02  | $1.63  |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | (0.01) | (0.64) | (0.48) | (0.31) |
| Net (loss) income per share attributable to Dole plc - basic | $(0.03) | $(0.41) | $0.54  | $1.32  |
| Income (loss) per share - diluted: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Continuing operations | $(0.02) | $0.23  | $1.01  | $1.62  |
| &nbsp;&nbsp;&nbsp;&nbsp;Discontinued operations | (0.01) | (0.64) | (0.48) | (0.30) |
| Net (loss) income per share attributable to Dole plc - diluted | $(0.03) | $(0.41) | $0.53  | $1.32  |
| Weighted-average shares: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Basic | 95163  | 95019  | 95145  | 94967  |
| &nbsp;&nbsp;&nbsp;Diluted | 96104  | 95702  | 95902  | 95471  |

---

------

**Consolidated Balance Sheets - Unaudited**

---

| | | |
|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2024** |
| **ASSETS** | *(U.S. Dollars and shares in thousands)* | *(U.S. Dollars and shares in thousands)* |
| Cash and cash equivalents | $267854  | $330017  |
| Short-term investments | 6418  | 6019  |
| Trade receivables, net of allowances for credit losses of $20,558 and $19,493, respectively | 539840  | 473511  |
| Grower advance receivables, net of allowances of $37,915 and $29,304, respectively | 143426  | 104956  |
| Other receivables, net of allowances of $17,027 and $15,248, respectively | 121355  | 125951  |
| Inventories, net of allowances of $3,659 and $4,178, respectively | 509260  | 430168  |
| Prepaid expenses | 70007  | 68918  |
| Other current assets | 17891  | 15111  |
| Fresh Vegetables current assets held for sale | —  | 281990  |
| Assets held for sale | 75689  | 1419  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current assets | **1751740**  | **1838060**  |
| Long-term investments  | 13827  | 14630  |
| Investments in unconsolidated affiliates | 142082  | 129322  |
| Actively marketed property | 53231  | 45778  |
| Property, plant and equipment, net of accumulated depreciation of $619,706 and $502,062, respectively | 1081656  | 1120366  |
| Operating lease right-of-use assets | 371366  | 341722  |
| Goodwill | 434345  | 429590  |
| DOLE® brand | 306280  | 306280  |
| Other intangible assets, net of accumulated amortization of $133,022 and $118,956, respectively | 18997  | 25238  |
| Other assets | 133931  | 112893  |
| Deferred tax assets, net | 88669  | 82484  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $**4396124**  | $**4446363**  |
| **LIABILITIES AND EQUITY** |  |  |
| Accounts payable | $712483  | $648591  |
| Income taxes payable | 21805  | 42753  |
| Accrued liabilities | 517989  | 443145  |
| Bank overdrafts | 9611  | 11443  |
| Current portion of long-term debt, net | 57668  | 80097  |
| Current maturities of operating leases | 71379  | 64357  |
| Payroll and other tax | 36320  | 28056  |
| Contingent consideration | 3252  | 3399  |
| Pension and postretirement benefits | 18699  | 18491  |
| Fresh Vegetables current liabilities held for sale | —  | 214387  |
| Liabilities held for sale | 14047  | —  |
| Dividends payable and other current liabilities | 31228  | 14696  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total current liabilities | **1494481**  | **1569415**  |
| Long-term debt, net | 799814  | 866075  |
| Operating leases, less current maturities | 306566  | 280896  |
| Deferred tax liabilities, net | 90100  | 84712  |
| Income taxes payable, less current portion | —  | 6210  |
| Contingent consideration, less current portion | 500  | 4007  |
| Pension and postretirement benefits, less current portion | 135900  | 129870  |
| Other long-term liabilities | 66990  | 70260  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | $**2894351**  | $**3011445**  |
| Redeemable noncontrolling interests | 29716  | 35554  |
| Stockholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp;Common stock — $0.01 par value; 300,000 shares authorized and 95,163 and 95,041 shares outstanding as of December 31, 2025 and December 31, 2024, respectively | 952  | 950  |
| &nbsp;&nbsp;&nbsp;Additional paid-in capital | 804247  | 801099  |
| &nbsp;&nbsp;&nbsp;Retained earnings | 676371  | 657430  |
| &nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (117467) | (166180) |
| Total equity attributable to Dole plc | **1364103**  | **1293299**  |
| Equity attributable to noncontrolling interests | 107954  | 106065  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total equity | **1472057**  | **1399364**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities, redeemable noncontrolling interests and equity | $**4396124**  | $**4446363**  |

---

------

**Consolidated Statements of Cash Flows - Unaudited**

---

| | | |
|:---|:---|:---|
| | **Year Ended** | **Year Ended** |
| | **December 31, 2025** | **December 31, 2024** |
| **Operating Activities** | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| &nbsp;&nbsp;&nbsp;Net income | $81975  | $143419  |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | 45959  | 28880  |
| Income from continuing operations | 127934  | 172299  |
| Adjustments to reconcile income from continuing operations to net cash provided by (used in) operating activities - continuing operations: |  |  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization | 112661  | 98818  |
| &nbsp;&nbsp;&nbsp;Impairment of goodwill | —  | 36684  |
| &nbsp;&nbsp;&nbsp;Impairment and asset write-downs of property, plant and equipment and lease assets | 11518  | 5480  |
| &nbsp;&nbsp;&nbsp;Net gain on sale of assets | (15045) | (2648) |
| &nbsp;&nbsp;&nbsp;Net gain on sale of businesses | (606) | (76417) |
| &nbsp;&nbsp;&nbsp;Net loss (gain) on financial instruments | 20308  | (12397) |
| &nbsp;&nbsp;&nbsp;Stock-based compensation expense | 6854  | 7951  |
| &nbsp;&nbsp;&nbsp;Equity method earnings | (30714) | (8308) |
| &nbsp;&nbsp;&nbsp;Amortization of debt discounts and debt issuance costs | 4127  | 7746  |
| &nbsp;&nbsp;&nbsp;Deferred tax expense (benefit) | 12975  | (17588) |
| &nbsp;&nbsp;&nbsp;Pension and other postretirement benefit plan expense | 7485  | 5404  |
| &nbsp;&nbsp;&nbsp;Dividends received from equity method investees | 12688  | 7049  |
| &nbsp;&nbsp;&nbsp;Gain on insurance proceeds | (17447) | —  |
| &nbsp;&nbsp;&nbsp;Other | 363  | (247) |
| Changes in operating assets and liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;Receivables, net of allowances | (124817) | (20603) |
| &nbsp;&nbsp;&nbsp;Inventories | (67998) | (70810) |
| &nbsp;&nbsp;&nbsp;Prepaids, other current assets and other assets | 2692  | (281) |
| &nbsp;&nbsp;&nbsp;Accounts payable, accrued liabilities and other liabilities | 60228  | 130589  |
| &nbsp;&nbsp;&nbsp;Net cash provided by operating activities - continuing operations | 123206  | 262721  |
| **Investing Activities** |  |  |
| &nbsp;&nbsp;&nbsp;Sales of assets | 13645  | 5011  |
| &nbsp;&nbsp;&nbsp;Capital expenditures | (121497) | (82435) |
| &nbsp;&nbsp;&nbsp;Proceeds from sale of businesses, net of transaction costs and cash transferred | 68621  | 117935  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds | 19606  | 527  |
| &nbsp;&nbsp;&nbsp;Sales (purchases) of unconsolidated affiliates | 3152  | (1769) |
| &nbsp;&nbsp;&nbsp;Acquisitions, net of cash acquired | (2248) | (926) |
| &nbsp;&nbsp;&nbsp;Other | (276) | (2563) |
| Net cash (used in) provided by investing activities - continuing operations | (18997) | 35780  |
| **Financing Activities** |  |  |
| &nbsp;&nbsp;&nbsp;Proceeds from borrowings and overdrafts | 1838112  | 1517106  |
| &nbsp;&nbsp;&nbsp;Repayments on borrowings and overdrafts and payment of debt refinancing fees | (1926927) | (1696130) |
| &nbsp;&nbsp;&nbsp;Dividends paid to shareholders  | (31568) | (30551) |
| &nbsp;&nbsp;&nbsp;Dividends paid to noncontrolling interests and other noncontrolling interest activity, net | (28076) | (26703) |
| &nbsp;&nbsp;&nbsp;Payments of contingent consideration | (2801) | (1567) |
| Net cash used in financing activities - continuing operations | (151260) | (237845) |
| &nbsp;&nbsp;&nbsp;Effect of foreign currency exchange rate changes on cash | 17724  | (15241) |
| &nbsp;&nbsp;&nbsp;Net cash (used in) provided by operating activities - discontinued operations | (27912) | 22592  |
| &nbsp;&nbsp;&nbsp;Net cash used in investing activities - discontinued operations | (6626) | (13293) |
| Cash (used in) provided by discontinued operations, net | (34538) | 9299  |
| (Decrease) increase in cash and cash equivalents | (63865) | 54714  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents at beginning of period, including discontinued operations | 331719  | 277005  |
| &nbsp;&nbsp;&nbsp;Cash and cash equivalents at end of period, including discontinued operations | $267854  | $331719  |
| **Supplemental cash flow information:** |  |  |
| &nbsp;&nbsp;&nbsp;Income tax payments, including discontinued operations, net of refunds | $(100100) | $(77967) |
| &nbsp;&nbsp;&nbsp;Interest payments on borrowings | $(63685) | $(67397) |
| **Non-cash Investing and Financing Activities:** |  |  |
| &nbsp;&nbsp;&nbsp;Accrued property, plant and equipment | $(2724) | $(2983) |

---

------

**Reconciliation from Net Income to Adjusted EBITDA – Unaudited**

The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Year Ended** | **Year Ended** |
| | **December 31, 2025** | **December 31, 2024** | **December 31, 2025** | **December 31, 2024** |
|  | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| **Net income (loss) (Reported GAAP)** | $**6002**  | $**(31597)** | $**81975**  | $**143419**  |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | 803  | 61231  | 45959  | 28880  |
| **Income from continuing operations (Reported GAAP)** | 6805  | 29634  | 127934  | 172299  |
| &nbsp;&nbsp;&nbsp;Income tax expense | 21821  | 264  | 71003  | 75649  |
| &nbsp;&nbsp;&nbsp;Interest expense | 15202  | 18055  | 66541  | 72264  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | (3316) | (11356) | 18753  | (10139) |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | (1076) | (90) | (12254) | (125) |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | (54) | (472) | (606) | (76417) |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | (4938) | (187) | (16812) | (2878) |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | 2403  | 740  | 10611  | 740  |
| &nbsp;&nbsp;&nbsp;Impairment of goodwill | —  | —  | —  | 36684  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | 3203  | 459  | 3786  | 459  |
| &nbsp;&nbsp;&nbsp;Debt refinancing expenses | —  | —  | 3182  | —  |
| &nbsp;&nbsp;&nbsp;Other items<sup>1,2</sup> | 801  | 11  | 1115  | (7) |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | 239  | 9294  | 867  | 16258  |
| **Adjusted EBIT (Non-GAAP)** | **41090**  | **46352**  | **274120**  | **284787**  |
| &nbsp;&nbsp;&nbsp;Depreciation | 27228  | 24410  | 105559  | 91262  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | 1788  | 1776  | 7102  | 7556  |
| &nbsp;&nbsp;&nbsp;Depreciation and amortization adjustments from equity method investments | 2561  | 2073  | 8595  | 8598  |
| **Adjusted EBITDA (Non-GAAP)** | $**72667**  | $**74611**  | $**395376**  | $**392203**  |

---

<sup>1</sup> For the three months ended December 31, 2025, other items is primarily comprised of $2.2 million of acquisition and transaction costs, partially offset by $1.5 million of interest income on deferred transaction consideration. For the three months ended December 31, 2024, other items is primarily comprised of various immaterial items.

<sup>2</sup> For the year ended December 31, 2025, other items is primarily comprised of $2.2 million of acquisition and transaction costs, partially offset by $1.5 million of interest income on deferred transaction consideration. For the year ended December 31, 2024, other items is primarily comprised of various immaterial items.

------

**Reconciliation from Net Income attributable to Dole plc to Adjusted Net Income – Unaudited**

The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item. Refer to the Appendix for supplementary detail.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended** | **Three Months Ended** | **Year Ended** | **Year Ended** |
| | **December 31, 2025** | **December 31, 2024** | **December 31, 2025** | **December 31, 2024** |
|  | *(U.S. Dollars and shares in thousands, except per share amounts)* | *(U.S. Dollars and shares in thousands, except per share amounts)* | *(U.S. Dollars and shares in thousands, except per share amounts)* | *(U.S. Dollars and shares in thousands, except per share amounts)* |
| **Net (loss) income attributable to Dole plc (Reported GAAP)** | $**(2664)** | $**(39149)** | $**51319**  | $**125513**  |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | 803  | 61231  | 45959  | 28880  |
| **Income from continuing operations attributable to Dole plc** | **(1861)** | **22082**  | **97278**  | **154393**  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | 1788  | 1776  | 7102  | 7556  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | (3316) | (11356) | 18753  | (10139) |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | (1076) | (90) | (12254) | (125) |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | (54) | (472) | (606) | (76417) |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | (4938) | (187) | (16812) | (2878) |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | 2403  | 740  | 10611  | 740  |
| &nbsp;&nbsp;&nbsp;Impairment of goodwill | —  | —  | —  | 36684  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | 3203  | 459  | 3786  | 459  |
| &nbsp;&nbsp;&nbsp;Debt refinancing expenses | —  | —  | 3182  | —  |
| &nbsp;&nbsp;&nbsp;Other items<sup>3,4</sup> | 2279  | 11  | 2593  | (7) |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | (2955) | 7926  | (10115) | 9708  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | 17338  | (5338) | 12846  | 13162  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | 978  | (271) | (1324) | (12239) |
| **Adjusted Net Income for Adjusted EPS calculation (Non-GAAP)** | $**13789**  | $**15280**  | $**115040**  | $**120897**  |
| Adjusted earnings per share – basic (Non-GAAP) | $0.14  | $0.16  | $1.21  | $1.27  |
| Adjusted earnings per share – diluted (Non-GAAP) | $0.14  | $0.16  | $1.20  | $1.27  |
| Weighted average shares outstanding – basic | 95163  | 95019  | 95145  | 94967  |
| Weighted average shares outstanding – diluted | 96104  | 95702  | 95902  | 95471  |

---

<sup>3</sup> For the three months ended December 31, 2025, other items is primarily comprised of $2.2 million of acquisition and transaction costs. For the three months ended December 31, 2024, other items is primarily comprised of various immaterial items.

<sup>4</sup> For the year ended December 31, 2025, other items is primarily comprised of $2.2 million of acquisition and transaction costs. For the year ended December 31, 2024, other items is primarily comprised of various immaterial items.

------

**Supplemental Reconciliation from Net Income attributable to Dole plc to Adjusted Net Income – Unaudited**

The following information is provided to give quantitative information related to items impacting comparability. Refer to the 'Non-GAAP Financial Measures' section of this document for additional detail on each item.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* |  |
| | **Revenue, net** | **Cost of sales** | **Gross profit** | **Gross Margin %** | **Selling, marketing, general and administration expenses** | **Other operating items<sup>5</sup>** | **Operating Income** |  |
| **Reported (GAAP)** | $**2366161**  | **(2207527)** | **158634**  | ***6.7*** <br>*%*** | **(129135)** | **(1809)** | $**27690**  |  |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | —  | —  | —  |  | —  | —  | —  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | —  | —  | —  |  | 1788  | —  | 1788  |  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | —  | (2393) | (2393) |  | —  | —  | (2393) |  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | —  | —  | —  |  | —  | (1076) | (1076) |  |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | —  | —  | —  |  | —  | (54) | (54) |  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | —  | 544  | 544  |  | —  | —  | 544  |  |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | —  | —  | —  |  | —  | 2403  | 2403  |  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | —  | —  | —  |  | 3204  | —  | 3204  |  |
| &nbsp;&nbsp;&nbsp;Debt refinancing expenses | —  | —  | —  |  | —  | —  | —  |  |
| &nbsp;&nbsp;&nbsp;Other items | —  | 54  | 54  |  | —  | —  | 54  |  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | —  | —  | —  |  | —  | —  | —  |  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | —  | —  | —  |  | —  | —  | —  |  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | —  | —  | —  |  | —  | —  | —  |  |
| **Adjusted (Non-GAAP)** | $**2366161**  | **(2209322)** | **156839**  |  | ***6.6*** <br>*%*** | **(124143)** | **(536)** | $**32160**  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* |  |
| | **Revenue, net** | **Cost of sales** | **Gross profit** | **Gross Margin %** | **Selling, marketing, general and administration expenses** | **Other operating items**<sup>6</sup> | **Operating Income** |  |
| **Reported (GAAP)** | $**2167464**  | **(2009045)** | **158419**  | ***7.3*** <br>*%*** | **(122675)** | **(935)** | $**34809**  |  |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | —  | —  | —  |  | —  | —  | —  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | —  | —  | —  |  | 1776  | —  | 1776  |  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | —  | (378) | (378) |  | —  | —  | (378) |  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | —  | —  | —  |  | —  | (90) | (90) |  |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | —  | —  | —  |  | —  | (472) | (472) |  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | —  | (187) | (187) |  | —  | —  | (187) |  |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | —  | —  | —  |  | —  | 740  | 740  |  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | —  | —  | —  |  | 459  | —  | 459  |  |
| &nbsp;&nbsp;&nbsp;Other items | —  | 11  | 11  |  | —  | —  | 11  |  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | —  | —  | —  |  | —  | —  | —  |  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | —  | —  | —  |  | —  | —  | —  |  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | —  | —  | —  |  | —  | —  | —  |  |
| **Adjusted (Non-GAAP)** | $**2167464**  | **(2009599)** | **157865**  |  | ***7.3*** <br>*%*** | **(120440)** | **(757)** | $**36668**  |

---

<sup>5</sup> Other operating items for the three months ended December 31, 2025 is comprised of $2.9 million of impairment charges and asset write-downs of property, plant and equipment, partially offset by a $1.1 million gain on asset sales and a $0.1 million gain on the disposal of businesses, as reported in the consolidated statements of operations.

<sup>6</sup> Other operating items for the three months ended December 31, 2024 is comprised of $2.2 million of impairment charges and asset write-downs of property, plant and equipment, partially offset by a $0.7 million gain on asset sales and a $0.5 million gain on the disposal of businesses, as reported in the consolidated statements of operations.

------

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* |
| | **Other income (expense), net** | **Interest income** | **Interest expense** | **Income tax expense** | **Equity earnings** | **Income from continuing operations** | **Loss from discontinued operations, net of income taxes** |
| **Reported (GAAP)** | $**4876**  | **3900**  | **(15202)** | **(21821)** | **7362**  | **6805**  | $**(803)** |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | —  | —  | —  | —  | —  | —  | 803  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | —  | —  | —  | —  | —  | 1788  | —  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | (923) | —  | —  | —  | —  | (3316) | —  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | —  | —  | —  | —  | —  | (1076) | —  |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | —  | —  | —  | —  | —  | (54) | —  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | (5482) | —  | —  | —  | —  | (4938) | —  |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | —  | —  | —  | —  | —  | 2403  | —  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | —  | —  | —  | —  | —  | 3204  | —  |
| &nbsp;&nbsp;&nbsp;Debt refinancing expenses | —  | —  | —  | —  | —  | —  | —  |
| &nbsp;&nbsp;&nbsp;Other items | 2224  | —  | —  | —  | —  | 2278  | —  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | —  | —  | —  | —  | (2955) | (2955) | —  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | —  | —  | —  | 17386  | (48) | 17338  | —  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | —  | —  | —  | —  | —  | —  | —  |
| **Adjusted (Non-GAAP)** | $**695**  | **3900**  | **(15202)** | **(4435)** | **4359**  | **21477**  | $**—**  |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* |
| | **Other income (expense), net** | **Interest income** | **Interest expense** | **Income tax expense** | **Equity earnings** | **Income from continuing operations** | **Loss from discontinued operations, net of income taxes** |
| **Reported (GAAP)** | $**11137**  | **2410**  | **(18055)** | **(264)** | **(403)** | **29634**  | $**(61231)** |
| &nbsp;&nbsp;&nbsp;Loss (income) from discontinued operations, net of income taxes | —  | —  | —  | —  | —  | —  | 61231  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | —  | —  | —  | —  | —  | 1776  | —  |
| &nbsp;&nbsp;&nbsp;Mark to market losses | (10978) | —  | —  | —  | —  | (11356) | —  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | —  | —  | —  | —  | —  | (90) | —  |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | —  | —  | —  | —  | —  | (472) | —  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | —  | —  | —  | —  | —  | (187) | —  |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | —  | —  | —  | —  | —  | 740  | —  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | —  | —  | —  | —  | —  | 459  | —  |
| &nbsp;&nbsp;&nbsp;Other items | —  | —  | —  | —  | —  | 11  | —  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | —  | —  | —  | —  | 7926  | 7926  | —  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | —  | —  | —  | (5240) | (98) | (5338) | —  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | —  | —  | —  | —  | —  | —  | —  |
| **Adjusted (Non-GAAP)** | $**159**  | **2410**  | **(18055)** | **(5504)** | **7425**  | **23103**  | $**—**  |

---

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended December 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* |  |
| | **Net income (loss)**  | **Net income attributable to noncontrolling interests** | **Net (loss) income attributable to Dole plc** | **Diluted net income per share** |  |
| **Reported (GAAP)** | $**6002**  | **(8666)** | $**(2664)** | $**(0.03)** |  |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | 803  | —  | 803  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | 1788  | —  | 1788  |  |  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | (3316) | —  | (3316) |  |  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | (1076) | —  | (1076) |  |  |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | (54) | —  | (54) |  |  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | (4938) | —  | (4938) |  |  |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | 2403  | —  | 2403  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | 3204  | —  | 3204  |  |  |
| &nbsp;&nbsp;&nbsp;Debt refinancing expenses | —  | —  | —  |  |  |
| &nbsp;&nbsp;&nbsp;Other items | 2278  | —  | 2278  |  |  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | (2955) | —  | (2955) |  |  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | 17338  | —  | 17338  |  |  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | —  | 978  | 978  |  |  |
| **Adjusted (Non-GAAP)** | $**21477**  | **(7688)** | $**13789**  |  | $**0.14**  |
| **Weighted average shares outstanding – diluted** |  |  | 96104  |  |  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Three Months Ended December 31, 2024**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* |  |
| | **Net income (loss)** | **Net income attributable to noncontrolling interests** | **Net (loss) income attributable to Dole plc** | **Diluted net income per share** |  |
| **Reported (GAAP)** | $**(31597)** | **(7552)** | $**(39149)** | $**(0.41)** |  |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | 61231  | —  | 61231  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | 1776  | —  | 1776  |  |  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | (11356) | —  | (11356) |  |  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | (90) | —  | (90) |  |  |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | (472) | —  | (472) |  |  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | (187) | —  | (187) |  |  |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | 740  | —  | 740  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | 459  | —  | 459  |  |  |
| &nbsp;&nbsp;&nbsp;Other items | 11  | —  | 11  |  |  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | 7926  | —  | 7926  |  |  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | (5338) | —  | (5338) |  |  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | —  | (271) | (271) |  |  |
| **Adjusted (Non-GAAP)** | $**23103**  | **(7823)** | $**15280**  |  | $**0.16**  |
| **Weighted average shares outstanding – diluted** |  |  | 95702  |  |  |

---

------

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* |  |
| | **Revenue, net** | **Cost of sales** | **Gross profit** | **Gross Margin %** | **Selling, marketing, general and administration expenses** | **Other operating items<sup>7</sup>** | **Operating Income** |  |
| **Reported (GAAP)** | $**9172907**  | **(8458599)** | **714308**  | ***7.8*** <br>*%*** | **(495476)** | **4133**  | $**222965**  |  |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | —  | —  | —  |  | —  | —  | —  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | —  | —  | —  |  | 7102  | —  | 7102  |  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | —  | (517) | (517) |  | —  | —  | (517) |  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | —  | —  | —  |  | —  | (12254) | (12254) |  |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | —  | —  | —  |  | —  | (606) | (606) |  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | —  | (1342) | (1342) |  | —  | —  | (1342) |  |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | —  | —  | —  |  | —  | 10611  | 10611  |  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | —  | —  | —  |  | 3786  | —  | 3786  |  |
| &nbsp;&nbsp;&nbsp;Debt refinancing expenses | —  | —  | —  |  | —  | —  | —  |  |
| &nbsp;&nbsp;&nbsp;Other items | —  | 226  | 226  |  | 130  | —  | 356  |  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | —  | —  | —  |  | —  | —  | —  |  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | —  | —  | —  |  | —  | —  | —  |  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | —  | —  | —  |  | —  | —  | —  |  |
| **Adjusted (Non-GAAP)** | $**9172907**  | **(8460232)** | **712675**  |  | ***7.8*** <br>*%*** | **(484458)** | **1884**  | $**230101**  |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* |
| | **Revenue, net** | **Cost of sales** | **Gross profit** | **Gross Margin %** | **Selling, marketing, general and administration expenses** | **Other operating items**<sup>8</sup> | **Operating Income** |
| **Reported (GAAP)** | $**8475343**  | **(7757622)** | **717721**  | ***8.5*** <br>*%*** | **(474058)** | **36901**  | $**280564**  |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | —  | —  | —  |  | —  | —  | —  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | —  | —  | —  |  | 7556  | —  | 7556  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | —  | (228) | (228) |  | —  | —  | (228) |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | —  | —  | —  |  | —  | (125) | (125) |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | —  | —  | —  |  | —  | (76417) | (76417) |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | —  | (2878) | (2878) |  | —  | —  | (2878) |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | —  | —  | —  |  | —  | 740  | 740  |
| &nbsp;&nbsp;&nbsp;Impairment of goodwill | —  | —  | —  |  | —  | 36684  | 36684  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | —  | —  | —  |  | 459  | —  | 459  |
| &nbsp;&nbsp;&nbsp;Other items | —  | 73  | 73  |  | —  | —  | 73  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | —  | —  | —  |  | —  | —  | —  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | —  | —  | —  |  | —  | —  | —  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | —  | —  | —  |  | —  | —  | —  |
| **Adjusted (Non-GAAP)** | $**8475343**  | **(7760655)** | **714688**  | ***8.4*** <br>*%*** | **(466043)** | **(2217)** | $**246428**  |

---

<sup>7</sup> Other operating items for the year ended December 31, 2025 is comprised of a $15.0 million gain on asset sales and a $0.6 million gain on the disposal of businesses, partially offset by an $11.5 million of impairment charges and asset write-downs of property, plant and equipment and lease assets, as reported in the consolidated statements of operations.

<sup>8</sup> Other operating items for the year ended December 31, 2024 is comprised of a $76.4 million gain on the disposal of businesses and a $2.6 million gain on asset sales, partially offset by a $36.7 million impairment charge of goodwill and $5.5 million of impairment charges and asset write-downs of property, plant and equipment, as reported in the consolidated statements of operations.

------

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars in thousands)* |
| | **Other income (expense), net** | **Interest income** | **Interest expense** | **Income tax expense** | **Equity earnings** | **Income from continuing operations** | **Loss from discontinued operations, net of income taxes** |
| **Reported (GAAP)** | $**(1574)** | **13373**  | **(66541)** | **(71003)** | **30714**  | **127934**  | $**(45959)** |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | —  | —  | —  | —  | —  | —  | 45959  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | —  | —  | —  | —  | —  | 7102  | —  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | 19270  | —  | —  | —  | —  | 18753  | —  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | —  | —  | —  | —  | —  | (12254) | —  |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | —  | —  | —  | —  | —  | (606) | —  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | (15470) | —  | —  | —  | —  | (16812) | —  |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | —  | —  | —  | —  | —  | 10611  | —  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | —  | —  | —  | —  | —  | 3786  | —  |
| &nbsp;&nbsp;&nbsp;Debt refinancing expenses | 3182  | —  | —  | —  | —  | 3182  | —  |
| &nbsp;&nbsp;&nbsp;Other items | 2237  | —  | —  | —  | —  | 2593  | —  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | —  | —  | —  | —  | (10115) | (10115) | —  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | —  | —  | —  | 12258  | 588  | 12846  | —  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | —  | —  | —  | —  | —  | —  | —  |
| **Adjusted (Non-GAAP)** | $**7645**  | **13373**  | **(66541)** | **(58745)** | **21187**  | **147020**  | $**—**  |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars in thousands)* |
| | **Other income (expense), net** | **Interest income** | **Interest expense** | **Income tax expense** | **Equity earnings** | **Income from continuing operations** | **Loss from discontinued operations, net of income taxes** |
| **Reported (GAAP)** | $**20595**  | **10745**  | **(72264)** | **(75649)** | **8308**  | **172299**  | $**(28880)** |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | —  | —  | —  | —  | —  | —  | 28880  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | —  | —  | —  | —  | —  | 7556  | —  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | (9911) | —  | —  | —  | —  | (10139) | —  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | —  | —  | —  | —  | —  | (125) | —  |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | —  | —  | —  | —  | —  | (76417) | —  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | —  | —  | —  | —  | —  | (2878) | —  |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | —  | —  | —  | —  | —  | 740  | —  |
| &nbsp;&nbsp;&nbsp;Impairment of goodwill | —  | —  | —  | —  | —  | 36684  | —  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | —  | —  | —  | —  | —  | 459  | —  |
| &nbsp;&nbsp;&nbsp;Other items | (80) | —  | —  | —  | —  | (7) | —  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | —  | —  | —  | —  | 9708  | 9708  | —  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | —  | —  | —  | 13560  | (398) | 13162  | —  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | —  | —  | —  | —  | —  | —  | —  |
| **Adjusted (Non-GAAP)** | $**10604**  | **10745**  | **(72264)** | **(62089)** | **17618**  | **151042**  | $**—**  |

---

&nbsp;&nbsp;&nbsp;&nbsp;

------

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Year Ended December 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* |  |
| | **Year Ended December 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Year Ended December 31, 2025**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* |  |
| | **Net income (loss)**  | **Net income attributable to noncontrolling interests** | **Net (loss) income attributable to Dole plc** | **Diluted net income per share** |  |
| **Reported (GAAP)** | $**81975**  | **(30656)** | $**51319**  | $**0.54**  |  |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | 45959  | —  | 45959  |  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | 7102  | —  | 7102  |  |  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | 18753  | —  | 18753  |  |  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | (12254) | —  | (12254) |  |  |
| &nbsp;&nbsp;&nbsp;Gain on disposal of businesses | (606) | —  | (606) |  |  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | (16812) | —  | (16812) |  |  |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | 10611  | —  | 10611  |  |  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | 3786  | —  | 3786  |  |  |
| &nbsp;&nbsp;&nbsp;Debt refinancing expenses | 3182  | —  | 3182  |  |  |
| &nbsp;&nbsp;&nbsp;Other items | 2593  | —  | 2593  |  |  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | (10115) | —  | (10115) |  |  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | 12846  | —  | 12846  |  |  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | —  | (1324) | (1324) |  |  |
| **Adjusted (Non-GAAP)** | $**147020**  | **(31980)** | $**115040**  |  | $**1.20**  |
| **Weighted average shares outstanding – diluted** |  |  | 95902  |  |  |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Year Ended December 31, 2024**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* |
| | **Year Ended December 31, 2024**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* | **Year Ended December 31, 2024**<br>*(U.S. Dollars and shares in thousands, except per share amounts)* |
| | **Net income (loss)** | **Net income attributable to noncontrolling interests** | **Net (loss) income attributable to Dole plc** | **Diluted net income per share** |
| **Reported (GAAP)** | $**143419**  | **(17906)** | $**125513**  | $**1.31**  |
| &nbsp;&nbsp;&nbsp;Loss from discontinued operations, net of income taxes | 28880  | —  | 28880  |  |
| &nbsp;&nbsp;&nbsp;Amortization of intangible assets | 7556  | —  | 7556  |  |
| &nbsp;&nbsp;&nbsp;Mark to market (gains) losses | (10139) | —  | (10139) |  |
| &nbsp;&nbsp;&nbsp;Gain on asset sales | (125) | —  | (125) |  |
| &nbsp;&nbsp;&nbsp;Gain on disposal of business | (76417) | —  | (76417) |  |
| &nbsp;&nbsp;&nbsp;Insurance proceeds, net of asset write-downs | (2878) | —  | (2878) |  |
| &nbsp;&nbsp;&nbsp;Impairment of property, plant and equipment and lease assets | 740  | —  | 740  |  |
| &nbsp;&nbsp;&nbsp;Impairment of goodwill | 36684  | —  | 36684  |  |
| &nbsp;&nbsp;&nbsp;Restructuring and costs for legal matters | 459  | —  | 459  |  |
| &nbsp;&nbsp;&nbsp;Other items | (7) | —  | (7) |  |
| &nbsp;&nbsp;&nbsp;Adjustments from equity method investments | 9708  | —  | 9708  |  |
| &nbsp;&nbsp;&nbsp;Income tax on items above and discrete tax items | 13162  | —  | 13162  |  |
| &nbsp;&nbsp;&nbsp;NCI impact on items above | —  | (12239) | (12239) |  |
| **Adjusted (Non-GAAP)** | $**151042**  | **(30145)** | $**120897**  | $**1.27**  |
| **Weighted average shares outstanding – diluted** |  |  | 95471  |  |

---

------

**Supplemental Reconciliation of Prior Year Segment Results to Current Year Segment Results – Unaudited**

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Revenue for the Three Months Ended** | **Revenue for the Three Months Ended** | **Revenue for the Three Months Ended** | **Revenue for the Three Months Ended** | **Revenue for the Three Months Ended** |
| | **December 31, 2024** | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | **December 31, 2025** |
|  | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| Fresh Fruit | $819066  | $217  | $—  | $54753  | $874036  |
| Diversified Fresh Produce - EMEA | 910604  | 76978  | (3015) | 41320  | 1025887  |
| Diversified Fresh Produce - Americas & ROW | 463285  | (58) | —  | 23228  | 486455  |
| Intersegment | (25491) | —  | —  | 5275  | (20216) |
| **Total** | $2167464  | $77137  | $(3015) | $124576  | $2366162  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Adjusted EBITDA for the Three Months Ended** | **Adjusted EBITDA for the Three Months Ended** | **Adjusted EBITDA for the Three Months Ended** | **Adjusted EBITDA for the Three Months Ended** | **Adjusted EBITDA for the Three Months Ended** |
| | **December 31, 2024** | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | **December 31, 2025** |
|  | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| Fresh Fruit | $31890  | $(382) | $178  | $(5084) | $26602  |
| Diversified Fresh Produce - EMEA | 32487  | 3723  | (96) | (3517) | 32597  |
| Diversified Fresh Produce - Americas & ROW | 10234  | (99) | (750) | 4083  | 13468  |
| **Total** | $74611  | $3242  | $(668) | $(4518) | $72667  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Revenue for the Year Ended** | **Revenue for the Year Ended** | **Revenue for the Year Ended** | **Revenue for the Year Ended** | **Revenue for the Year Ended** |
| | **December 31, 2024** | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | **December 31, 2025** |
|  | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| Fresh Fruit | $3293527  | $754  | $—  | $320846  | $3615127  |
| Diversified Fresh Produce - EMEA | 3608692  | 171992  | (31678) | 267567  | 4016573  |
| Diversified Fresh Produce - Americas & ROW | 1686281  | (3388) | (79307) | 52621  | 1656207  |
| Intersegment | (113157) | —  | —  | (1843) | (115000) |
| **Total** | $8475343  | $169358  | $(110985) | $639191  | $9172907  |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Adjusted EBITDA for the Year Ended** | **Adjusted EBITDA for the Year Ended** | **Adjusted EBITDA for the Year Ended** | **Adjusted EBITDA for the Year Ended** | **Adjusted EBITDA for the Year Ended** |
| | **December 31, 2024** | Impact of Foreign Currency Translation | Impact of Acquisitions and Divestitures | Like-for-like Increase (Decrease) | **December 31, 2025** |
|  | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| Fresh Fruit | $214848  | $(744) | $565  | $(24827) | $189842  |
| Diversified Fresh Produce - EMEA | 131504  | 8349  | 42  | 10086  | 149981  |
| Diversified Fresh Produce - Americas & ROW | 45851  | (451) | (2724) | 12877  | 55553  |
| **Total** | $392203  | $7154  | $(2117) | $(1864) | $395376  |

---

------

**Net Debt and Net Leverage Reconciliation – Unaudited**

Net Debt is the primary measure used by management to analyze the Company's capital structure. Net Debt is a non-GAAP financial measure, calculated as cash and cash equivalents, less current and long-term debt. It also excludes debt discounts and debt issuance costs. Net Leverage is calculated as total Net Debt divided by Last Twelve Months ("LTM") Adjusted EBITDA as of the period end. The calculation of Net Debt and Net Leverage as of December 31, 2025 is presented below. Net Debt as of December 31, 2025 was $606.5 million and Net Leverage was 1.5x.

---

| | | |
|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2024** |
|  | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| Cash and cash equivalents (Reported GAAP) | $267854  | $330017  |
| Debt (Reported GAAP): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Long-term debt, net | (799814) | (866075) |
| &nbsp;&nbsp;&nbsp;&nbsp;Current maturities | (57668) | (80097) |
| &nbsp;&nbsp;&nbsp;&nbsp;Bank overdrafts | (9611) | (11443) |
| Total debt, net | (867093) | (957615) |
| Less: Debt discounts and debt issuance costs (Reported GAAP) | (7237) | (9531) |
| Total gross debt | (874330) | (967146) |
| **Net Debt (Non-GAAP)** | $**(606476)** | $**(637129)** |
| LTM Adjusted EBITDA (Non-GAAP) | 395376  | 392203  |
| **Net Leverage (Non-GAAP)** | **1.5x** | **1.6x** |
| **Last Twelve Months ("LTM") Adjusted EBITDA** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;FY'25 Adjusted EBITDA | 395376  | 392203  |
| **LTM Adjusted EBITDA** | $395376  | $392203  |

---

**Free Cash Flow from Continuing Operations Reconciliation – Unaudited**

---

| | | |
|:---|:---|:---|
| | **Year Ended** | **Year Ended** |
| | **December 31, 2025** | **December 31, 2024** |
|  | *(U.S. Dollars in thousands)* | *(U.S. Dollars in thousands)* |
| Net cash provided by operating activities - continuing operations (Reported GAAP) | $123206  | $262721  |
| Less: Capital expenditures (Reported GAAP)<sup>9</sup> | (121497) | (82435) |
| **Free cash flow from continuing operations (Non-GAAP)** | $1709  | $180286  |

---

<sup>9</sup> Capital expenditures do not include amounts attributable to discontinued operations.

------

**Non-GAAP Financial Measures**

Dole plc's results are determined in accordance with U.S. GAAP.

In addition to its results under U.S. GAAP, in this Press Release, we also present Dole plc's Adjusted EBIT, Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, Free Cash Flow from Continuing Operations, Net Debt and Net Leverage, which are supplemental measures of financial performance that are not required by, or presented in accordance with, U.S. GAAP (collectively, the "non-GAAP financial measures"). We present these non-GAAP financial measures, because we believe they assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. These non-GAAP financial measures have limitations as analytical tools, and you should not consider them in isolation or as a substitute for analysis of our operating results, cash flows or any other measure prescribed by U.S. GAAP. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by any of the adjusted items or that any projections and estimates will be realized in their entirety or at all. In addition, adjustment items that are excluded from non-GAAP results can have a material impact on equivalent GAAP earnings, financial measures and cash flows.

Adjusted EBIT is calculated from GAAP net income by: (1) subtracting the income or adding the loss from discontinued operations, net of income taxes; (2) adding the income tax expense or subtracting the income tax benefit; (3) adding interest expense; (4) adding mark to market losses or subtracting mark to market gains related to unrealized impacts from certain derivative instruments and foreign currency denominated borrowings, realized impacts on noncash settled foreign currency denominated borrowings, net foreign currency impacts on liquidated entities and fair value movements on contingent consideration; (5) other items which are separately stated based on materiality, which during the three months and years ended December 31, 2025 and December 31, 2024, included adding impairment charges on goodwill, adding or subtracting asset write-downs from extraordinary events, net of insurance proceeds, subtracting the gain or adding the loss on the disposal of business interests, subtracting the gain or adding the loss on asset sales for assets held for sale and actively marketed property or sales-type leases, adding impairment charges or held for sale classification losses on property, plant and equipment and lease assets, subtracting interest income on deferred transaction consideration, adding acquisition and transaction costs, adding restructuring charges and costs for legal matters not in the ordinary course of business and adding debt refinancing expenses; and (6) the Company's share of these items from equity method investments.

Adjusted EBITDA is calculated from GAAP net income by: (1) subtracting the income or adding the loss from discontinued operations, net of income taxes; (2) adding the income tax expense or subtracting the income tax benefit; (3) adding interest expense; (4) adding depreciation charges; (5) adding amortization charges on intangible assets; (6) adding mark to market losses or subtracting mark to market gains related to unrealized impacts from certain derivative instruments and foreign currency denominated borrowings, realized impacts on noncash settled foreign currency denominated borrowings, net foreign currency impacts on liquidated entities and fair value movements on contingent consideration; (7) other items which are separately stated based on materiality, which during the three months and years ended December 31, 2025 and December 31, 2024, included adding impairment charges on goodwill, adding or subtracting asset write-downs from extraordinary events, net of insurance proceeds, subtracting the gain or adding the loss on the disposal of business interests, subtracting the gain or adding the loss on asset sales for assets held for sale and actively marketed property, adding impairment charges or held for sale classification losses on property, plant and equipment and lease assets, subtracting interest income on deferred transaction consideration, adding acquisition and transaction costs, adding restructuring charges and costs for legal matters not in the ordinary course of business and adding debt refinancing expenses; and (8) the Company's share of these items from equity method investments.

Last Twelve Months ("LTM") Adjusted EBITDA is calculated as Adjusted EBITDA, as defined above, for the last twelve months as of the period end, which for the year ended December 31, 2025 and December 31, 2024, is the same as Adjusted EBITDA.

Adjusted Net Income is calculated from GAAP net income attributable to Dole plc by: (1) subtracting the income or adding the loss from discontinued operations, net of income taxes; (2) adding amortization charges on intangible assets; (3) adding mark to market losses or subtracting mark to market gains related to unrealized impacts from certain derivative instruments and foreign currency denominated borrowings, realized impacts on noncash settled foreign currency denominated borrowings, net foreign currency impacts on liquidated entities and fair value movements on contingent consideration; (4) other items which are separately stated based on materiality, which during the three months and years ended December 31, 2025 and December 31, 2024, included adding impairment charges on goodwill, adding or subtracting asset write-downs from extraordinary events, net of insurance proceeds, subtracting the gain or adding the loss on the disposal of business interests, subtracting the gain or adding the loss on asset sales for assets held for sale and actively marketed property, adding impairment charges or held for sale classification losses on property, plant and equipment and lease assets, adding acquisition and transaction costs, adding restructuring charges and costs for legal matters not in the ordinary course of business and adding debt refinancing expenses; (5) the Company's share of these items from equity method investments; (6) excluding the tax effect of these items and discrete tax adjustments; and (7) excluding the effect of these items attributable to non-controlling interests.

Adjusted Earnings per Share is calculated from Adjusted Net Income divided by diluted weighted average number of shares in the applicable period.

Net Debt is a non-GAAP financial measure, calculated as GAAP cash and cash equivalents, less GAAP current and long-term debt. It also excludes GAAP unamortized debt discounts and debt issuance costs.

Net Leverage is a non-GAAP financial measure, calculated as Net Debt divided by LTM Adjusted EBITDA, both of which are defined above.

Free cash flow from continuing operations is calculated from GAAP net cash used in or provided by operating activities for continuing operations less GAAP capital expenditures.

------

Like-for-like basis refers to the U.S. GAAP measure or non-GAAP financial measure excluding the impact of foreign currency translation movements and acquisitions and divestitures. The impact of foreign currency translation represents an estimate of the effect of translating the results of operations denominated in a foreign currency to U.S. dollar at prior year average rates, as compared to the current year average rates.

Dole is not able to provide a reconciliation for projected FY'26 results without taking unreasonable efforts.

<br>